Zvi Laron | Academic Influence

Zvi Laron's AcademicInfluence.com Rankings

Zvi Laron

Philosophy

#3149

World Rank

#5154

Historical Rank

Logic

#1112

World Rank

#1764

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Zvi Laron's Degrees

Doctorate Medicine University of Buenos Aires

Why Is Zvi Laron Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Zvi Laron is an Israeli paediatric endocrinologist. Born in Cernăuţi, Romania, Laron is a professor emeritus at Tel Aviv University. In 1966, he described the type of dwarfism later called Laron syndrome. His research opened the way to the treatment of many cases of growth hormone disorders. He was the first to introduce the multidisciplinary treatment for juvenile diabetes.

(See a Problem?)

Zvi Laron's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Growth Hormone Deficiency in Adulthood and the Effects of Growth Hormone Replacement: A Review (1998) (800)
Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. (1998) (675)
Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism. (1989) (561)
Insulin-like growth factor 1 (IGF-1): a growth hormone (2001) (474)
Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958-2003. (2004) (355)
Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. (1998) (262)
Mathematical formulae for the prediction of the residual beta cell function during the first two years of disease in children and adolescents with insulin-dependent diabetes mellitus. (1995) (251)
Geographic Differences in the Risk of Insulin-dependent Diabetes Mellitus: The Importance of Registries (1985) (251)
Effects of insulin-like growth factor on linear growth, head circumference, and body fat in patients with Laron-type dwarfism (1992) (212)
Administration of growth hormone to patients with familial dwarfism with high plasma immunoreactive growth hormone: measurement of sulfation factor, metabolic and linear growth responses. (1971) (202)
IGF-I is critical for normal vascularization of the human retina. (2002) (196)
Congenital IGF1 deficiency tends to confer protection against post-natal development of malignancies. (2011) (192)
ORAL CLONIDINE AS A GROWTH HORMONE STIMULATION TEST (1979) (182)
Insulin analogues display IGF‐I‐like mitogenic and anti‐apoptotic activities in cultured cancer cells (2009) (178)
Patients with congenital deficiency of IGF-I seem protected from the development of malignancies: a preliminary report. (2007) (171)
Pituitary dwarfism with high serum levels of growth hormone. (1968) (170)
Defect of human growth hormone receptors in the liver of two patients with Laron-type dwarfism. (1984) (153)
Final height of girls with central precocious puberty, untreated versus treated with cyproterone acetate or GnRH analogue. A comparative study with re-evaluation of predictions by the Bayley-Pinneau method. (1997) (142)
Relationship between the incidence of type 1 diabetes and maternal enterovirus antibodies: time trends and geographical variation (2005) (139)
Diagnosis and management of growth hormone deficiency in childhood and adolescence. Part 1: diagnosis of growth hormone deficiency. (2001) (129)
Laron-type dwarfism (hereditary somatomedin deficiency): a review. (1984) (125)
Serum levels of insulin-like growth factor (IGF) and its carrier protein in various metabolic disorders. (1980) (120)
Growth curves for Laron syndrome. (1993) (116)
SERUM GROWTH HORMONE BINDING PROTEIN ACTIVITY IN HEALTHY NEONATES, CHILDREN AND YOUNG ADULTS: CORRELATION WITH AGE, HEIGHT AND WEIGHT (1989) (109)
Response of plasma LH and FSH to synthetic LH-RH in children at various pubertal stages. (1976) (108)
Three Year IGF-I Treatment of Children with Laron Syndrome (1995) (106)
Effect of insulin-like growth factor-I treatment on serum androgens and testicular and penile size in males with Laron syndrome (primary growth hormone resistance). (1998) (105)
Paternity in Klinefelter's syndrome--a case report. (1982) (103)
Do deficiencies in growth hormone and insulin-like growth factor-1 (IGF-1) shorten or prolong longevity? (2005) (101)
EFFECT OF ACUTE ADMINISTRATION OF INSULIN-LIKE GROWTH FACTOR I IN PATIENTS WITH LARON-TYPE DWARFISM (1988) (98)
Comparative skeletal features between Homo floresiensis and patients with primary growth hormone insensitivity (Laron Syndrome). (2007) (94)
The essential role of IGF-I: lessons from the long-term study and treatment of children and adults with Laron syndrome. (1999) (93)
The "Little People" of the Island of Krk - Revisited. Etiology of Hypopituitarism Revealed (1999) (91)
A Multidisciplinary, Comprehensive, Ambulatory Treatment Scheme for Diabetes Mellitus in Children (1979) (88)
Natural history of the classical form of primary growth hormone (GH) resistance (Laron syndrome). (1999) (86)
Defective sulfation factor generation: a possible etiological link in dwarfism. (1969) (84)
The GH-IGF1 axis and longevity. The paradigm of IGF1 deficiency (2008) (82)
Intranasal administration of the GHRP hexarelin accelerates growth in short children (1995) (80)
Body composition in untreated adult patients with Laron syndrome (primary GH insensitivity) (2006) (80)
Body fat in Laron syndrome patients: effect of insulin-like growth factor I treatment. (1993) (76)
Incidence of Type 1 diabetes mellitus in children aged 0–14 in Japan, 1986–1990, including an analysis for seasonality of onset and month of birth: JDS study (2000) (76)
Seasonality of Birth and Onset of Clinical Disease in Children and Adolescents (0-19 Years) with Type 1 Diabetes Mellitus in Canterbury, New Zealand (2002) (76)
Effect of insulin‐like growth factor‐1 deficiency or administration on the occurrence of acne (2011) (75)
Crisis Intervention Program in Newly Diagnosed Diabetic Children (1982) (74)
Biochemical and hormonal changes induced by one week of administration of rIGF‐I to patients with Laron type dwarfism (1991) (74)
Is obesity associated with early sexual maturation? (2004) (73)
INSULIN‐LIKE GROWTH FACTOR I (IGF‐I) IN HEALTHY CHILDREN, ADOLESCENTS AND ADULTS AS DETERMINED BY A RADIOIMMUNOASSAY SPECIFIC FOR THE SYNTHETIC 53–70 PEPTIDE REGION (1986) (71)
Pubertal development, growth and final height in girls with sexual precocity after therapy with the GnRH analogue D-TRP-6-LHRH. A report on 15 girls, followed after cessation of gonadotrophin suppressive therapy. (1990) (71)
Late onset 21-hydroxylase deficiency and HLA in the Ashkenazi population: a new allele at the 21-hydroxylase locus. (1980) (69)
Carbohydrate metabolism in primary growth hormone resistance (Laron syndrome) before and during insulin-like growth factor-I treatment. (1995) (68)
Laron syndrome: clinical features, molecular pathology and treatment. (1994) (66)
Prismatic cases: Laron syndrome (primary growth hormone resistance) from patient to laboratory to patient. (1995) (66)
Variation by age group and seasonally at diagnosis of childhood IDDM in Europe (1995) (65)
Delayed growth and puberty in patients with Gaucher disease type 1: natural history and effect of splenectomy and/or enzyme replacement therapy. (2000) (63)
LESSONS FROM 50 YEARS OF STUDY OF LARON SYNDROME. (2015) (63)
Is the Laron mouse an accurate model of Laron syndrome? (1999) (63)
Long-term treatment of Laron type dwarfs with insulin-like growth factor-1 increases serum insulin-like growth factor-binding protein-3 in the absence of growth hormone activity. (1993) (62)
Premature Thelarche–Natural History and Sex Hormone Secretion in 68 Girls (1984) (61)
Growth Hormone Insensitivity (Laron Syndrome) (2002) (61)
Comparison of dental findings in patients with isolated growth hormone deficiency treated with human growth hormone (hGH) and in untreated patients with Laron-type dwarfism. (1988) (61)
Laron syndrome due to a post-receptor defect: response to IGF-I treatment. (1993) (60)
Growth hormone increases plasma levels of insulin-like growth factor (IGF-I) in a teleost, the gilthead seabream (sparus aurata). (1989) (60)
Serum GH binding protein activities identifies the heterozygous carriers for Laron type dwarfism. (1989) (58)
Up-regulation of insulin-like growth factor-I (IGF-I) receptor gene expression in patients with reduced serum IGF-I levels. (1993) (58)
THE EUROPEAN SOCIETY FOR PAEDIATRIC ENDOCRINOLOGY (1968) (57)
Bloom's syndrome. VI. The disorder in Israel and an estimation of the gene frequency in the Ashkenazim. (1977) (57)
Insulin and the brain (2009) (56)
Secretion of growth hormone, prolactin and corticosteroids during different levels of geomagnetic activity (1983) (56)
Growth hormone (GH) stimulates insulin-like growth factor-I (IGF-I) and IGF-I-binding protein-3, but not GH receptor gene expression in livers of juvenile rats. (1993) (56)
Ectopic thyroid gland. A clinical study of 30 children and review. (1978) (55)
A unique association of short stature, dysmorphic features, and speech impairment (Floating-Harbor syndrome). (1988) (54)
Diagnosis and management of growth hormone deficiency in childhood and adolescence--part 2: growth hormone treatment in growth hormone deficient children. (2002) (53)
Puberty in 24 patients with Klinefelter syndrome (1982) (53)
Effect of aging on human plasma growth hormone response to clonidine (1984) (53)
Receptor mutations and haplotypes in growth hormone receptor deficiency: a global survey and identification of the Ecuadorean E180splice mutation in an oriental Jewish patient (1994) (53)
D-TRP6-ANALOGUE OF LUTEINISING HORMONE RELEASING HORMONE IN COMBINATION WITH CYPROTERONE ACETATE TO TREAT PRECOCIOUS PUBERTY (1974) (52)
Plasma cortisol, prolactin, growth hormone, and immunoreactive beta-endorphin response to fenfluramine challenge in depressed patients. (1988) (52)
Puberty in Laron type dwarfism (1980) (52)
IGF-I deficiency, longevity and cancer protection of patients with Laron syndrome. (2017) (51)
Laron syndrome - from man to mouse (2011) (51)
Long-term IGF-I treatment of children with Laron syndrome increases adiposity. (2006) (50)
Nonalcoholic fatty liver in patients with Laron syndrome and GH gene deletion - preliminary report. (2008) (50)
IGF binding protein 3 in patients with Laron type dwarfism: effect of exogenous rIGF‐I (1992) (50)
Total and high molecular weight adiponectin are elevated in patients with Laron syndrome despite marked obesity. (2009) (50)
JUVENILE HYPOTHYROIDISM WITH TESTICULAR ENLARGEMENT (1970) (48)
Receptor-active growth hormone in Laron dwarfism. (1976) (48)
Insulinlike growth factor I affects ocular development: a study of untreated and treated patients with Laron syndrome. (2006) (47)
Seasonality in clinical onset of Type 1 diabetes in Belgian patients above the age of 10 is restricted to HLA-DQ2/DQ8-negative males, which explains the male to female excess in incidence (2004) (47)
Pituitary growth hormone insufficiency associated with cleft lip and palate. An embryonal developmental defect. (1969) (47)
Insulin-like growth factor-I treatment of children with Laron syndrome (primary growth hormone insensitivity). (2008) (46)
Seasonality of Birth Month of Children With Celiac Disease Differs From That in the General Population and Between Sexes and Is Linked to Family History and Environmental Factors (2009) (46)
Month of Birth and Subsequent Development of Type I Diabetes (IDDM) (1999) (46)
Episodic hormone secretion during sleep in Kleine-Levin syndrome: Evidence for hypothalamic dysfunction (1987) (46)
TREATMENT OF PRECOCIOUS PUBERTY WITH LHRH ANALOGUE IN COMBINATION WITH CYPROTERONE ACETATE—FURTHER EXPERIENCE (1984) (46)
Intravenous administration of recombinant IGF-I lowers serum GHRH and TSH. (1990) (45)
Cephalometric measurements of familial dwarfism and high plasma immunoreactive growth hormone. (1975) (45)
IGF-I treatment of adult patients with Laron syndrome: preliminary results. (1994) (44)
Fifty seven years of follow-up of the Israeli cohort of Laron Syndrome patients-From discovery to treatment. (2016) (44)
Cyproterone acetate in treatment of precocious puberty. (1976) (44)
Age at first conscious ejaculation: A milestone in male puberty. (1979) (43)
Skull changes in pituitary dwarfism and the syndrome of familial dwarfism with high plasma immunoreactive growth hormone--a Roentgenologic study. (1972) (43)
Growth hormone increases and insulin-like growth factor-I decreases circulating lipoprotein(a) (1997) (42)
Seasonality of month of birth of patients with Graves' and Hashimoto's diseases differ from that in the general population. (2007) (42)
The Incidence of Insulin-dependent Diabetes Mellitus in Israeli Children and Adolescents 0–20 Years of Age: A Retrospective Study, 1975–1980 (1985) (42)
Craniofacial and brain abnormalities in Laron syndrome (primary growth hormone insensitivity). (2002) (42)
Comparative effects of GH, IGF‐I and insulin on serum sex hormone binding globulin (1994) (42)
Hypothalamo-pituitary hormone insufficiency associated with cleft lip and palate. (1978) (41)
Abnormal growth hormone response to LRH and TRH in adolescent schizophrenic boys. (1981) (41)
Growth hormone-releasing activity of growth hormone-releasing peptide-1 (a synthetic heptapeptide) in children and adolescents. (1993) (41)
Desensitization from long-term intranasal treatment with hexarelin does not interfere with the biological effects of this growth hormone-releasing peptide in short children. (1996) (41)
Intellectual and psychosocial functions of children, adolescents and young adults before and after operation for craniopharyngioma. (1981) (41)
Lack of placental transfer of human growth hormone. (1966) (40)
Seasonality of month of birth of children and adolescents with type 1 diabetes mellitus in homogenous and heterogeneous populations. (2005) (40)
Laron Syndrome (Primary Growth Hormone Insensitivity): A Unique Model to Explore the Effect of Insulin-Like Growth Factor 1 Deficiency on Human Hair (2004) (40)
The comparative effect of 6α-fluoroprednisolone, 6α-methylprednisolone, and hydrocortisone on linear growth of children with congenital adrenal virilism and Addison's disease (1968) (40)
Effects of acute and chronic methylphenidate administration on beta-endorphin, growth hormone, prolactin and cortisol in children with attention deficit disorder and hyperactivity. (1987) (39)
Diurnal rhythm of plasma beta endorphin, cortisol and growth hormone in schizophrenics as compared to control subjects (2004) (39)
The Pattern of Growth in Children with Constitutional Tall Stature from Birth to Age 9 Years (1984) (39)
Growth hormone resistance. (1980) (38)
Interplay between heredity and environment in the recent explosion of type 1 childhood diabetes mellitus. (2002) (38)
A retrospective study of the incidence of diagnosed Type 1 diabetes among children and adolescents in a large health organization in Israel, 2000–2008 (2011) (38)
Low Plasma Immunoreactive β‐Endorphin Levels in Autism (1988) (37)
Echocardiographic dimensions and function in adults with primary growth hormone resistance (Laron syndrome). (2000) (37)
Human growth hormone receptors in human circulating lymphocytes. (1975) (37)
Long-acting insulin analogues elicit atypical signalling events mediated by the insulin receptor and insulin-like growth factor-I receptor (2010) (37)
Identification of thioredoxin-interacting protein (TXNIP) as a downstream target for IGF1 action (2018) (36)
Diabetic retinopathy in two patients with congenital IGF-I deficiency (Laron syndrome). (2004) (36)
The syndrome of familial dwarfism and high plasma immunoreactive human growth hormone. (1974) (35)
Lack of Seasonality in the Month of Onset of Childhood IDDM (0.7-15 years ) in Shanghai, China (1998) (35)
Effects of growth hormone and insulin-like growth factor 1 deficiency on ageing and longevity. (2002) (35)
THE IMPACT OF LONG‐TERM THERAPY BY A MULTIDISCIPLINARY TEAM ON THE EDUCATION, OCCUPATION AND MARITAL STATUS OF GROWTH HORMONE DEFICIENT PATIENTS AFTER TERMINATION OF THERAPY (1987) (35)
Cochlear hearing loss in patients with Laron syndrome (2012) (34)
Intellectual function of girls with precocious puberty. (1984) (34)
Seasonality of Birth in Children (0-14 years) and Young Adults (0-29 years) with Type 1 Diabetes Mellitus in Sardinia Differs from that in the General Population (2001) (34)
Genetic aspects of pituitary dwarfism due to absence or biological inactivity of growth hormone. (1968) (34)
Measurement of human growth hormone. Description of the method and its clinical applications. (1966) (34)
Skin turgor as a quantitative index of dehydration in children. (1957) (34)
Mortality of patients with childhood onset (0–17 years) Type I diabetes in Israel: a population-based study (2001) (33)
Somatomedin-1 (Recombinant Insulin-Like Growth Factor-1) (2012) (33)
Laron Syndrome: From Description to Therapy (1993) (33)
Hormones and Sport (1989) (33)
[Estrogen treatment of excessively tall girls]. (1976) (33)
Muscle force and endurance in untreated and human growth hormone or insulin-like growth factor-I-treated patients with growth hormone deficiency or Laron syndrome. (1997) (32)
The early postnatal development of the murine mandibular condyle is regulated by endogenous insulin-like growth factor-I. (1993) (32)
Insulin receptor compensates for IGF1R inhibition and directly induces mitogenic activity in prostate cancer cells (2014) (32)
Effect of insulin-like growth factor I on the thyroid axis in patients with Laron-type dwarfism and healthy subjects. (1992) (31)
Comparison of the growth‐promoting effects of insulin‐like growth factor I and growth hormone in the early years of life (2000) (31)
Prevention of Hypoglycemic Attacks by Propranolol in a Patient Suffering from Insulinoma (1975) (30)
Insulin, growth, and growth hormone. (1972) (30)
Are adult patients with Laron syndrome osteopenic? A comparison between dual-energy X-ray absorptiometry and volumetric bone densities. (2003) (29)
TOTAL DEFICIENCY OF CORTICOSTEROID‐BINDING GLOBULIN (1984) (29)
Follow-up of boys with unilateral compensatory testicular hypertrophy. (1980) (29)
Characterization of a noncontiguous gene deletion of the growth hormone receptor in Laron's syndrome. (1993) (29)
Growth hormone, glucose, and free fatty acid levels in mother and infant in normal, diabetic and toxaemic pregnancies. (1967) (29)
EFFECT OF HUMAN GROWTH HORMONE THERAPY ON HEAD CIRCUMFERENCE IN CHILDREN WITH HYPOPITUITARISM (1979) (29)
A vasopressin analogue in treatment of diabetes insipidus (1974) (28)
Insulin enhances the growth of cartilage in organ and tissue cultures of mouse neonatal mandibular condyle (1993) (28)
Glycogen metabolism in the placenta of streptozotocin diabetic rats. (1978) (28)
Immunoreactive properties of the plasma hGH from patients with the syndrome of familial dwarfism and high plasma IR-hGH. (1973) (28)
Identification of signaling pathways associated with cancer protection in Laron syndrome. (2016) (28)
Recurrent hypothermia, hypersomnolence, central sleep apnea, hypodipsia, hypernatremia, hypothyroidism, hyperprolactinemia and growth hormone deficiency in a boy--treatment with clomipramine. (1986) (28)
IGF‐I treatment of adult patients with Laron syndrome: preliminary results (1994) (28)
Longevity of the hypopituitary patients from the island Krk: a follow-up study. (2010) (28)
The effect of acute and repeated electroconvulsive treatment on plasma β-endorphin, growth hormone, prolactin and cortisol secretion in depressed patients (2005) (27)
A COMPARATIVE STUDY OF THE EFFECT OF OESTROGEN SUBSTITUTION THERAPY ON BREAST DEVELOPMENT IN GIRLS WITH HYPO—AND HYPERGONADOTROPHIC HYPOGONADISM (1982) (27)
Differences Between Males and Females in the Seasonality of Birth and Month of Clinical Onset of Disease in Children with Type I Diabetes Mellitus in Ireland (2003) (27)
Insulin-like growth factor-I decreases serum lipoprotein (a) during long-term treatment of patients with Laron syndrome. (1996) (27)
The intellectual capacity of patients with Laron syndrome (LS) differs with various molecular defects of the growth hormone receptor gene. Correlation with CNS abnormalities. (2005) (27)
Hypothyroidism due to ectopy in siblings. (1977) (26)
GONADAL FUNCTION IN BLOOM'S SYNDROME (1977) (26)
Obese adults with primary growth hormone resistance (Laron Syndrome) have normal endothelial function. (2007) (26)
The incidence of infantile pyloric stenosis. (1957) (26)
Growth hormone and insulin-like growth factor regulate insulin-like growth factor-binding protein-1 in Laron type dwarfism, growth hormone deficiency and constitutional short stature. (1992) (26)
Immunoreactive β-endorphin, cortisol, and growth hormone plasma levels in obsessive-compulsive disorder (1990) (26)
Histopathological changes in the placenta of streptozotocin induced diabetic rats (1974) (26)
Growth, development, puberty and adult height before and during treatment in children with congenital isolated growth hormone deficiency. (2015) (26)
A Comparative Study on the Epidemiology of IDDM Between Japan, Norway, Israel and the United States (1984) (25)
Plasma LH and FSH response to LRH in boys with compensatory testicular hypertrophy. (1975) (25)
Genome-Wide Profiling of Laron Syndrome Patients Identifies Novel Cancer Protection Pathways (2019) (25)
DIFFERENTIAL DIAGNOSIS BETWEEN HYPOTHALAMIC AND PITUITARY hGH DEFICIENCY WITH THE AID OF SYNTHETIC GH‐RH 1–44 (1984) (25)
Growth hormone releasing activity by intranasal administration of a synthetic hexapeptide (hexarelin) (1994) (25)
Small Testes in Prepubertal Boys with Klinefelter's Syndrome (1971) (25)
Insulin–a growth hormone (2008) (24)
Final height of girls with Turner's syndrome: correlation with karyotype and parental height (1995) (24)
Head circumference in untreated and IGF-I treated patients with Laron syndrome: comparison with untreated and hGH-treated children with isolated growth hormone deficiency. (2012) (24)
The E180splice mutation in the GHR gene causing Laron syndrome: Witness of a Sephardic Jewish exodus from the Iberian Peninsula to the New World? (2014) (24)
IGF-1 and insulin as growth hormones. (2004) (24)
Consequences of not treating children with laron syndrome (primary growth hormone insensitivity). (2001) (24)
LOW ORAL DOSE OF CLONIDINE: AN EFFECTIVE SCREENING TEST FOR GROWTH HORMONE DEFICIENCY (1982) (23)
ADRENOCORTICAL FUNCTION IN CHILDREN WITH PRECOCIOUS SEXUAL DEVELOPMENT DURING TREATMENT WITH CYPROTERONE ACETATE (1982) (23)
PUBERTAL DEVELOPMENT IN THE PRADER‐LABHART‐WILLI SYNDROME (1978) (23)
Seasonality of month of birth differs between type 1 diabetes patients with pronounced beta‐cell autoimmunity and individuals with lesser or no beta‐cell autoimmunity * (2007) (23)
Laron syndrome abnormalities: spinal stenosis, os odontoideum, degenerative changes of the atlanto-odontoid joint, and small oropharynx. (2002) (23)
Cardiac dimension and function in patients with childhood onset growth hormone deficiency, before and after growth hormone retreatment in adult age. (2003) (23)
Growth hormone, somatomedin and prolactin — Relationship to brain function — (1985) (23)
Long-term effect of D-Trp6-luteinizing hormone-releasing hormone on testicular size and luteinizing hormone, follicle-stimulating hormone, and testosterone levels in hypothalamic hypogonadotropic males. (1981) (23)
Interactions between the thyroid hormones and the hormones of the growth hormone axis. (2003) (23)
Deficiencies of growth hormone and somatomedins in man. (1983) (22)
The effect of repeated injections of synthetic luteinizing hormone-releasing hormone on the response of plasma luteinizing hormone and follicle-stimulating hormone in young hypogonadotropic-hypogonadal patients. (1976) (22)
Growth hormone (hGH) secretion and turnover in three patients with Laron-type dwarfism. (1988) (22)
Somatotrophin in antenatal and perinatal growth and development. (1969) (22)
Genetic analysis of the pedigrees and molecular defects of the GH-receptor gene in the Israeli cohort of patients with Laron syndrome. (2006) (22)
Elimination characteristics of intravenously administered rIGF-I in Laron-type dwarfs. (1990) (22)
A contribution to Bloom's syndrome. Congenital telangiectatic erythema resembling lypus erythematosus in dwarfs. (1960) (22)
Effect of human growth hormone therapy on penile and testicular size in boys with isolated growth hormone deficiency: first year of treatment. (1983) (22)
Serum prolactin in patients with Laron-type dwarfism: effect of insulin-like growth factor I. (1992) (22)
GONADAL DYSFUNCTION IN PATIENTS WITH ATAXIA TELANGIECTASIA (1978) (21)
Essential Benign Fructosuria (1961) (21)
Adjustment and rehabilitation problems of children and adolescents with growth retardation. I. Familial dwarfism with high plasma immunoreactive human growth hormone. (1975) (21)
Seasonality of Birth in Children (0-14 Years) with Diabetes Mellitus Type 1 in Baden-Wuerttemberg, Germany (2000) (21)
Activity of acid phosphatase in the serum of normal infants and children. (1960) (21)
Congenital macrodactyly. A case report with a three-year follow-up. (1966) (21)
I-GF-1 signalling controls the hair growth cycle and the differentiation of hair shafts. (2006) (21)
Cardiorespiratory depression and plasma beta-endorphin levels in low-birth-weight infants during the first day of life. (1987) (20)
The obesity of patients with Laron Syndrome is not associated with excessive nutritional intake. (2009) (20)
Laron syndrome – A historical perspective (2020) (20)
Inhibition of insulin release and stimulation of growth hormone release by hypocalcemia in a boy. (1970) (20)
Plasma Disappearance of Various 131I-labelled Growth Hormone Preparations in Man and Rabbit (1965) (20)
IMMUNOCHEMICAL PROPERTIES OF BOVINE AND HUMAN PITUITARY GROWTH HORMONE AFTER PEPSIN DIGESTION. (1964) (19)
Plasma growth hormone response to synthetic GH-RH1-44 in 52 children and adults with growth hormone deficiency of various etiologies. (1985) (19)
Aspects of brain development in children and adolescents with pituitary growth hormone deficiency (1980) (19)
Glucose and insulin responses to an oral glucose load in normal children and adolescents in Israel. (1976) (19)
Growth hormone therapy: emerging dilemmas. (2011) (19)
Experience with Cyproterone Acetate in the Treatment of Precocious Puberty (2000) (19)
Effect of hGH on head circumference and IQ in isolated growth hormone deficiency. (1981) (19)
Molecular defects of the growth hormone receptor gene, including a new mutation, in Laron syndrome patients in Israel: relationship between defects and ethnic groups. (2004) (18)
Insulin Resistance in Laron Syndrome (Primary Insulin-like Growth Factor-I (IGF-I) Deficiency) and Effect of IGF-I Replacement Therapy (1997) (18)
Plasma growth hormone response to oral clonidine as compared to insulin hypoglycemia in obese children and adolescents. (2008) (18)
Age at first ejaculation (spermarche)--the overlooked milestone in male development. (2010) (18)
Renal function in Laron syndrome patients treated by insulin-like growth factor-I (1994) (18)
Effect of oral clonidine, insulin-induced hypoglycemia and exercise on plasma GHRH levels in short-stature children. (1990) (18)
Pituitary size in patients with Laron syndrome (primary GH insensitivity). (2003) (18)
Sodium Losing Material in Human Urine.∗ (1958) (18)
Insulin‐like growth factor‐I raises serum procollagen levels in children and adults with Laron syndrome (1996) (18)
Indications, limitations and pitfalls in the determination of human growth hormone, IGF-I and their binding proteins. (2007) (18)
Hepatitis Associated with Propylthiouracil Treatment (1985) (18)
Direct visualization of binding, aggregation and internalization of human growth hormone in cultured human lymphocytes. (1984) (18)
Growth hormone secretagogues. Clinical experience and therapeutic potential. (1995) (18)
Reduced exercise capacity in untreated adults with primary growth hormone resistance (Laron syndrome) (2003) (18)
THE COMBINED EFFECT OF GROWTH HORMONE AND METHANDROSTENOLONE ON THE LINEAR GROWTH OF PATIENTS WITH MULTIPLE PITUITARY HORMONE DEFICIENCIES (1977) (17)
Role of the GH-IGF1 system in progression of cancer (2020) (17)
Disorders of growth hormone resistance in childhood. (1993) (17)
Effect of anorexia nervosa on gonadotrophin secretion in a patient with gonadal dysgenesis (1982) (17)
Erythrocytes from patients with low serum concentrations of IGF-I have an increase in receptor sites for IGF-I. (1991) (17)
Rise in plasma growth hormone in response to exogenous LRH in Klinefelter's syndrome (1981) (17)
An update on Laron syndrome. (1993) (17)
Carbohydrate consumption and oral status of diabetic and nondiabetic young adolescents. (1985) (17)
Impact of the Gulf War on the anxiety, cortisol, and growth hormone levels of Israeli civilians. (1994) (17)
Differential effect of insulin-like growth factor-I and growth hormone on hypothalamic regulation of growth hormone secretion in the rat (1996) (17)
Plasma Growth Hormone in Men and Women over 70 Years of Age (1969) (17)
Long-term effects of insulin-like growth factor (IGF)-I on serum IGF-I, IGF-binding protein-3 and acid labile subunit in Laron syndrome patients with normal growth hormone binding protein. (1997) (17)
Increasing incidence of childhood obesity. (2004) (17)
The effect of dihydrosomatostatin in dwarfism with high plasma immunoreactive growth hormone. (1977) (16)
EFFECT OF l‐DOPA ON THE SECRETION OF PLASMA GROWTH HORMONE IN CHILDREN AND ADOLESCENTS (1973) (16)
Observations on a baby born to a mother with congenital adrenal hyperplasia. (1959) (16)
Clinical evidence on the role of oestrogens in the development of the breasts (1989) (16)
The development and progression of diabetic retinopathy in type I diabetic patients: a cohort study (1997) (16)
Controversies in the use of insulin analogues (2011) (16)
Metabolic substrates and hormones during starvation ketosis in children. (1968) (16)
EFFECTS OF 17ALPHA-HYDROXY-6ALPHA-METHYLPROGESTERONE ACETATE (DEPO-PROVERA) ON URINARY GONADOTROPHINS AND OESTROGENS IN MAN. (1963) (16)
Short stature due to genetic defects affecting growth hormone activity. (1996) (16)
Picture of the month. Laron-type dwarfism. (1991) (16)
PENILE SIZE AND GROWTH IN CHILDREN AND ADOLESCENTS WITH ISOLATED GONADOTROPHIN DEFIENCY (IGnD) (1977) (16)
Insulin secretion in children with constitutional familial short stature. (1973) (15)
Seasonality of month of birth of children and adolescents with type 1 diabetes mellitus in Berlin differs from the general population (2002) (15)
Human Chorionic Gonadotropin (hCG) Treatment in Cryptorchidism (1983) (15)
IGF-I replacement therapy in children with congenital IGF-I deficiency (Laron syndrome) maintains heart dimension and function. (2009) (15)
THE EFFECT OF METHANDROSTENOLONE ON PITUITARY GROWTH HORMONE SECRETION IN PREPUBERTAL CHILDREN (1972) (15)
Self-image in adolescents with delayed puberty and growth retardation (1981) (15)
CHANGES IN ENDOGENOUS INSULIN SECRETION DURING CHILDHOOD AS EXPRESSED BY PLASMA AND URINARY C‐PEPTIDE (1988) (15)
Long-term consequences of early feeding. (1996) (15)
Some properties of the plasma hGH activity in patients with Laron-type dwarfism determined by a radioreceptor assay using human liver tissue. (1985) (15)
The plasma 11-hydroxycorticosteroids responseto insulin-induced hypoglycaemia in children and adolescents. (1969) (15)
Development and biological function of the female gonads and genitalia in IGF-I deficiency -- Laron syndrome as a model. (2006) (15)
A questionnaire survey concerning the most favourable treatment for Graves' disease in children and adolescents. (2004) (14)
Diencephalic syndrome due to a suprasellar epidermoid cyst. Case report. (1983) (14)
Modulation of insulin like growth factor I (IGF-I) binding sites on erythrocytes by IGF-I treatment in patients with Laron syndrome (LS) (1993) (14)
WITHDRAWAL OF HUMAN PITUITARY GROWTH HORMONE (1985) (14)
Immunological behaviour of HGH from plasma of patients with familial dwarfism and high IR-HGH in a radioimmunoassay system using the cross-reaction between HGH and HCS. (1974) (14)
Growth hormone (GH) stimulates insulin-like growth factor-I (IGF-I) and IGF-binding protein (IGFBP)-2 gene expression in spleens of juvenile rats. (1994) (14)
Endocrinological parameters and cell-mediated immunity postoperation for cryptorchidism. (1988) (14)
Social, educational and vocational status of 48 young adult females with gonadal dysgenesis (1992) (14)
Growth Hormone Treatment Increases Circulating Lipoprotein(a) in Children with Chronic Renal Failure (1996) (14)
ADDISON'S DISEASE ASSOCIATED WITH PRECOCIOUS SEXUAL DEVELOPMENT IN A BOY (1981) (14)
Changes in bone mineral density after discontinuation and early reinstitution of growth hormone (GH) in patients with childhood-onset GH deficiency. (1999) (14)
DECREASED INSULIN-LIKE GROWTH FACTOR-I RECEPTOR SITES ON CIRCULATING MONONUCLEAR CELLS FROM CHILDREN WITH ACUTE LEUKEMIA (2000) (14)
Comparison of metabolic and psychological parameters during continuous subcutaneous insulin infusion and intensified conventional insulin treatment in type I diabetic patients. (1985) (14)
Acromegaly due to ectopic growth hormone-releasing hormone secretion by a bronchial carcinoid tumour. Dynamic hormonal responses to various stimuli. (1991) (14)
INTERMITTENT TREATMENT WITH HUMAN GROWTH HORMONE (GH) IN ISOLATED GH DEFICIENCY AND IN MULTIPLE PITUITARY HORMONE DEFICIENCIES (1976) (14)
Seasonality of birth of patients with juvenile idiopathic arthritis. (2015) (13)
Serum Leptin in Obese Patients with Laron Syndrome Before and During IGF-I Treatment (1998) (13)
Effect of acute and chronic administration of clonidine on hypothalamic content of growth hormone-releasing hormone and somatostatin in the rat. (1991) (13)
THE LH RESPONSE TO LH‐RELEASING HORMONE IN CHILDREN WITH TRUE ISOSEXUAL PRECOCIOUS PUBERTY TREATED WITH CYPROTERONE ACETATE (1975) (13)
ORAL CLONIDINE AS A GROWTH HORMONE STIMULATION TEST (1979) (13)
IAA/GAD-positive offspring of diabetic parents have a different seasonality in month of birth than antibody-negative offspring. (2001) (13)
The diagnostic and prognostic importance of neonatal length measurements. (2000) (13)
Histopathological features of the skin in hypopituitarism and Laron-type dwarfism. (1983) (13)
Laron Syndrome Research Paves the Way for New Insights in Oncological Investigation (2020) (13)
Proliferative and signaling activities of insulin analogues in endometrial cancer cells (2015) (13)
Responsiveness of pituitary hGH to GRH1-44 in juveniles with obesity. (1986) (13)
Immunoreactive beta-endorphin, cortisol, and growth hormone plasma levels in obsessive-compulsive disorder. (1990) (13)
Changes in blood glucose and plasma insulin, free fatty acids, growth hormone and 11-hydroxycorticosteroids during intramuscular vasopressin tests in children and adolescents. (1968) (13)
Insulin response to intravenous glucagon in children with familial constitutional short stature. (1975) (12)
Severe obstructive sleep apnoea syndrome in an adult patient with Laron syndrome. (2001) (12)
Effect of chlorpromazine on hypothalamic-pituitary-gonadal function in 10 adolescent schizophrenic boys. (1983) (12)
Eye findings in congenital telangiectatic erythema and growth retardation (Bloom's syndrome). (1966) (12)
Low-dose oral clonidine. (1985) (12)
Psycho-social problems of diabetic children and adolescents. (1984) (12)
Incidence of Hypertrophic Pyloric Stenosis in the Various Jewish Communities in Israel (1955) (12)
The interrelationship between cortisone and parathyroid extract in rats. (1958) (11)
Lessons from recent epidemiological studies in type 1 childhood diabetes. (1999) (11)
Abnormalities of the axial and proximal appendicular skeleton in adults with Laron syndrome (growth hormone insensitivity) (2008) (11)
Emerging treatment options for patients with Laron syndrome (2014) (11)
Mortality in Israeli Jewish patients with Type 1 (insulin-dependent) diabetes mellitus diagnosed prior to 18 years of age: a population based study (1991) (11)
The plasma FSH and LH response to synthetic LH-RH in normal pre-pubertal and early pubertal girls--a re-evaluation. (1979) (11)
Diabetic retinopathy, nephropathy and cardiovascular disease in a patient with GH gene deletion (2005) (11)
Laron-type dwarfism is associated with normal growth hormone and insulin-like growth factor I gene restriction patterns. (1989) (11)
Greater efficiency of human growth hormone therapy in children below five years of age with growth hormone deficiency. A 5-year follow-up study. (1987) (11)
Seasonality of Month of Birth of Children (0-14 Years Old) with Type 1 Diabetes Mellitus in the District of Catania (Sicily) (2001) (11)
Fifty years on: New lessons from Laron syndrome. (2017) (11)
FAT MOBILISING EFFECT OF OESTROGENS. (1965) (11)
Pubertal development in the Prader-Labhart-Willi syndrome. (1979) (10)
When should hydrocortisone therapy be instituted in children with hypopituitarism? (1988) (10)
The Role of Nuclear Insulin and IGF1 Receptors in Metabolism and Cancer (2021) (10)
PLASMA GLUCAGON RESPONSE TO ARGININE INFUSION IN CHILDREN AND ADOLESCENTS WITH DIABETES MELLITUS (1975) (10)
Changes in lipoprotein (a) levels measured by six kit methods during growth hormone treatment of growth hormone deficient adults. (2000) (10)
Abnormal Growth Hormone Response to TRH in Chronic Adolescent Schizophrenic Patients (1982) (10)
Increased number of IGF‐I receptors on erythrocytes of women with polycystic ovarian syndrome (1997) (10)
Type 2 diabetes mellitus in childhood--a global perspective. (2002) (10)
Insulin--a growth hormone. (2008) (10)
Serum Insulin-like Growth Factor-I (IGF-I) Levels During Long-term IGF-I Treatment of Children and Adults with Primary GH Resistance (Laron Syndrome) (1999) (10)
Foot Length Before and During Insulin-like Growth Factor-I Treatment of Children with Laron Syndrome Compared to Human Growth Hormone Treatment of Children with Isolated Growth Hormone Deficiency (2007) (10)
Evaluation of the renin-aldosterone system during hypo- and hyperglycemia in children and adolescents. (1980) (9)
Evaluation of testicular function in prepubertal boys by means of the luteinizing hormone-releasing hormone test. (1978) (9)
Modulation of IGF‐I receptors by exogenous hGH treatment in constitutionally short children (1993) (9)
Relationship between solar activity and levels of plasma growth hormone and prolactin (1989) (9)
Glucose tolerance and insulin secretion in parents and children with familial dwarfism and high plasma immunoreactive growth hormone (IR-HGH) and familial isolated growth hormone deficiency. (2009) (9)
Growth During and 2 Years After Stopping GH Treatment in Prepubertal Children with Idiopathic Short Stature (1997) (9)
Diabetes in juveniles. Medical and rehabilitation aspects. (1977) (9)
Renal and Vascular Disturbances in a Case of Thallium Poisoning (1954) (9)
Growth Hormone and Insulin-Like Growth Factor-I: Effects on the Brain (2009) (9)
MULTIPLE PITUITARY HORMONE DEFICIENCIES IN EIGHT SIBLINGS OF ONE JEWISH MOROCCAN FAMILY (1979) (9)
Confusion around the definition of small for gestational age (SGA). (2005) (9)
FURTHER EVIDENCE FOR A FAT MOBILIZING EFFECT OF ANDROGENS. (1964) (9)
Skin turgor as a quantitative index of dehydration in rats. (1957) (9)
If one daily injection of IGF-I has the same growth-promoting effect as 2 injections per day, why continue to give two injections? (2013) (9)
Immunochemical studies of human pituitary growth hormone. (1962) (8)
Identification of two novel mutations in the human growth hormone receptor gene (2003) (8)
Regulation of hypophyseal secretion by endogenous opiates: humoral endorphin stimulates the release of growth hormone. (1981) (8)
Anthropometric measurements in patients with growth hormone deficiency before treatment with human growth hormone (1980) (8)
Psychological aspects of developmental endocrinopathies in adolescence. (1994) (8)
Growth Hormone and Insulin-like Growth Factor IEffects on the Brain (2002) (8)
Juvenile Multiple Sclerosis Similar to Type I Diabetes Mellitus has a Seasonality of Month of Birth which Differs from that in the General Population (2008) (8)
Identification of ZYG11A as a candidate IGF1-dependent proto-oncogene in endometrial cancer (2019) (8)
Diabetic retinopathy in an adolescent with Prader-Labhart-Willi syndrome. (1974) (8)
A comparison of IGF-I levels measured by two commercially available radioimmunoassays. (1988) (8)
Beta‐endorphins in acute myocardial infarction (1986) (8)
Prolactin deficiency, obesity and enlarged testes - a new syndrome? (1979) (8)
Mortality and cancer incidence among patients treated with recombinant growth hormone during childhood in Israel (2016) (8)
Short Term Effect of Intranasal Administration of Hexarelin — A Synthetic Growth Hormone-Releasing Peptide. Preliminary Communication (1995) (8)
Congenital hereditary hypothyroidism—prenatal diagnosis and treatment (1990) (8)
Usefulness of the growth hormone-releasing hormone test regardless of which fragment is used (GHRH 1-44, 1-40 or 1-29). (1991) (8)
Treatment of Diabetes insipidus in Children and Adolescents (1985) (8)
Suppression of hypoglycemia by DL-propranolol in malignant insulinoma. (1978) (8)
Effect of different serum concentrations of growth hormone-binding protein (GHBP) on the regulation of GH receptor/GHBP gene transcription in a human hepatoma cell line. (1997) (8)
Classical Phenotype of Laron Syndrome in a Girl with a Heterozygous Mutation and Heterozygous Polymorphism of the Growth Hormone Receptor Gene (2004) (7)
Growth Hormone Releasing Peptide—Hexarelin—in Children: Biochemical and Growth Promoting Effects (1996) (7)
Sexual Development in Patients with Laron Syndrome (2011) (7)
Epilogue: The future of Laron syndrome - The need for changes. (2016) (7)
Serum Growth Hormone-Binding Protein (GHBP) Activity is Decreased by Administration of Insulin-Like Growth Factor I in Three Laron Syndrome Siblings with Normal GHBP (1994) (7)
Metabolic Activity of Individual Electrophoretic Fractions of Human Growth Hormone1 (1963) (7)
TREATMENT OF PRECOCIOUS SEXUAL DEVELOPMENT BY MEDROXYPROGESTERONE ACETATE (1965) (7)
THE EFFECT OF REPEATED INJECTIONS OF SYNTHETIC LH-RB ON THE RESPONSE OF PLASMA LH AND FSH IN YOUNG HYPOGONADOTROPHIC-HYPOGONADAL PATIENTS (1975) (7)
Growth in patients with isolated gonadotrophin deficiency. (1992) (7)
Comparative effect of corticosterone and cortisone on rat bones. (1962) (7)
The growth hormone-prolactin relationship: a neglected issue. (2011) (7)
Delayed puberty and hypoplastic uterus associated with hyperprolactinemia: successful treatment with bromocriptine. (1985) (7)
Genetic Mutations, Birth Lengths, Weights and Head Circumferences of Children with IGF-I Receptor Defects. Comparison with other Congenital Defects in the GH/IGF-I axis. (2016) (7)
The effect of methandrostenolone on pituitary growth hormone secretion. (1970) (7)
Serum acid phosphatase response to starvation and cortisone administration in rats. (1961) (7)
Seasonality of birth and Type 1 diabetes onset in children (0–14 years) in Cuba (2001) (7)
Clonidine: an effective growth hormone-releasing agent. (1983) (7)
Dynamics of basal pituitary gonadotropin secretion and responsiveness to LRH following estradiol benzoate in normal boys. (1982) (7)
Insulin Secretion and Carbohydrate Metabolism in Patients with Laron Syndrome: From Hypoglycemia to Diabetes Mellitus (2011) (7)
Nicolae C. Paulescu--scientist and politician. (2008) (7)
Growth hormone, lipoprotein(a) and cardiovascular disease. (1998) (7)
Incidence and Seasonality of Type 1 Diabetes Mellitus - What Now? (2002) (7)
Neuroeyndocrinological Response to Standardized Mixed Meal in Female Anorectic Patients During Active and Refeeding Phases (2000) (7)
Immunomodulation of streptozotocin-induced diabetes in mice by a lipopolysaccharide. (1984) (7)
Psychosocial Aspects of Young Adult Growth Hormone Deficient Patients Previously Treated with Human Growth Hormone‐ a Preliminary Report (1986) (7)
Differential effects of hGH and IGF-I on body proportions. (2012) (7)
Residual B cell function in diabetic children as determined by urinary C-peptide (1983) (7)
The Globe and Orbit in Laron Syndrome (2011) (7)
Prevalence of diabetes among children treated with growth hormone in Israel (2018) (6)
ACTIVITY OF ENDOGENOUS GROWTH HORMONE (1967) (6)
Myopathy associated with ketoconazole treatment. (1991) (6)
Occurrence of four types of growth hormone-related dwarfism in Israeli communities (1981) (6)
Immunological Properties of Electrophoretic Fractions of Human Growth Hormone (1962) (6)
Treatment of diabetes in children: revisited. (1974) (6)
Incidence of diabetes mellitus in various population groups in Israel (1989 and 1990). (1994) (6)
Use of Fluoxymesterone in the Treatment of Growth Retardation (1963) (6)
LINEAR GROWTH IN HYPOPITUITARY PATIENTS TREATED WITH hGH AFTER AGE FIFTEEN (1979) (6)
Lessons from Laron syndrome (LS) 1966-1992 : a model of GH and IGF-1 action and interaction : Ares-Serono symposium, Lisbon, May 25-26, 1992 (1993) (6)
Diagnosis of Growth Hormone Deficiency in Childhood (2000) (6)
McCune-Albright syndrome with sexual precocity in a boy. (1973) (6)
Effect of clonidine on plasma beta-endorphin, cortisol and growth hormone secretion in opiate-addicted subjects. (1985) (6)
Insulin-like growth factor-I (lGF-l): safety and efficacy. (2004) (6)
Comparison of the effect of insulin hypoglycemia and clonidine on secretion of growth hormone, cortisol and beta-endorphin in children and adolescents. (1985) (6)
The effect of insulin-like growth factor (IGF) and of human serum on steps in proteoglycan synthesis. (1981) (6)
Gynaecomastia in two prepubertal boys with congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency. (1979) (6)
Interventional catheterization decreases plasma levels of atrial natriuretic peptide (ANP) in children with congenital heart defects. (1998) (6)
Glucose Tolerance Tests and Insulin Response in Juvenile Patients with Gonadal Dysgenesis (1977) (6)
Effectiveness of fluoxymesterone on linear growth and weight in children with growth retardation and underweight. (1961) (6)
Is dietary intervention for the prevention of insulin-dependent diabetes mellitus feasible? Discussion (1993) (6)
Growth hormone therapy in normal short children induces a transitory decrease in plasma growth hormone releasing hormone levels and in human growth hormone responsiveness to exogenous growth hormone releasing hormone (1992) (6)
Laron syndrome. First report from Greece. (2003) (6)
Low plasma immunoreactive beta-endorphin levels in autism. (1988) (6)
Failure of 19-nor-androstenolone phenylpropionate (durabolin) to prevent the alterations produced by cortisone on the growing bone in rats. (1961) (6)
Prolactin secretion in 70 patients with growth hormone deficiency (1980) (6)
The young diabetic subjects in the Israel Army. (1994) (6)
Growth hormone releasing hormone (GH-RH, GRF)—an important new clinical tool (1986) (6)
Pubertal development in girls with sexual precocity after discontinuation of treatment with cyproterone acetate. (1980) (6)
Identification of nephronectin as a new target for IGF1 action. (2020) (6)
PROLACTIN SECRETION IN GIRLS WITH ISOLATED GONADOTROPHIN DEFICIENCY (1977) (6)
Medical aspects of balance of diabetes in juveniles (1977) (6)
Serum alkaline phosphatase response to the administration of cortisone in rats. (1957) (6)
Intronic Mutation in the Growth Hormone Receptor Gene in a Peruvian Girl with Laron Syndrome (2002) (6)
Hand Size and Growth in Untreated and IGF-I Treated Patients with Laron Syndrome (2009) (6)
The urgent need to prevent type 1 autoimmune childhood diabetes. (2015) (6)
ONE YEAR TREATMENT WITH ICF-1 OF CHILDREN WITH LARON SYNDROME (LS) (1993) (6)
Self-Monitoring of Blood Glucose During Pregnancy in Women with Juvenile Diabetes (1980) (5)
A contribution to the fat mobilizing activity of human grwoth hormone. (1968) (5)
The LH response to LH releasing hormone in children with true isosexual precocious puberty treated with cyproterone acetate. (1975) (5)
Insulin: A Growth Hormone and Potential Oncogene. (2020) (5)
Immunological properties of a human pituitary prolactin preparation. (1966) (5)
Acceleration of puberty in boys with delayed puberty by clomiphene citrate. A clinical and laboratory study. (1980) (5)
Opposing Effects of Growth Hormone and Insulin-like Growth Factor I on Serum Lipoprotein(a) (1997) (5)
Human chorionic gonadotropin stimulation of Leydig cell function in puberty. Comparison of testosterone response in plasma and urine. (1976) (5)
Biphasic response of subscapular skinfold thickness to hGH or IGF-1 administration to patients with congenital IGHD, congenital MPHD and Laron syndrome. (2014) (5)
Lifespan and Mortality of Patients with Laron Syndrome (2011) (5)
Moyamoya ' associated with peripheral vascular occlusive disease (5)
Basal plasma HGH and cortisol levels and the effect of clonidine administration in female migrainous patients. (1984) (5)
Definition and classification of diabetes (1989) (5)
Genetic predisposition to hypertension (as detected by Na+/Li+ countertransport) and risk of diabetic nephropathy in childhood diabetes (1994) (5)
Introduction: The History and Impact of the International Beilinson Symposia (2001) (5)
Clinical Evidence of Growth Hormone Resistance in Patients with Laron Syndrome (2011) (5)
Clinical use of growth hormone : present and future aspects : proceedings of the Second Meeting of the International Growth and Development Association (IGDA), Taormina on Sea, May 19-22, 1986 (1987) (5)
Genome-wide profiling of congenital insulin-like growth factor-1 deficient patients: translational implications in cancer prevention and metabolism (2017) (5)
The role of exogenous insulin in the pathogenesis of autoimmune diabetes mellitus. Discussion (1993) (5)
Suppression of hypoglycemic attacks and insulin release by propranolol in a patient with metastatic malignant insulinoma. (1977) (5)
Hormonal and local agents as extracellular regulators of cartilage growth measured by the rate of proteoglycan synthesis. A hypothesis. (1980) (5)
Hypoglycemia Due to Hormone Deficiencies (1998) (5)
Anthropometric indices of adolescents who at birth were full-term long and/or overweight for gestational age. (2012) (5)
Effect of Sodium Valproate on The Secretion of Prolactin, Cortisol and Growth Hormone in Migraine Patients (1992) (5)
Intranasally and orally active GH secretagogues are useful clinical tools: So why are they not on the market? (2003) (5)
Breast development induced by methandrostenolone (Dianabol). (1962) (5)
Effect of alendronate on bone mineral density in adult patients with Laron syndrome (primary growth hormone insensitivity). (2006) (5)
More on "diabetic control". (1978) (5)
Phenylketonuria in Jews (1960) (5)
DIAGNOSIS, TREATMENT AND FOLLOW-UP OF 326 CASES REFERRED AS UNDESCENDED TESTES (1965) (5)
Differential expression of IGFBPs in Laron syndrome-derived lymphoblastoid cell lines: Potential correlation with reduced cancer incidence. (2017) (5)
Nutrition and the diabetic child. (1979) (5)
Effectiveness of Growth Hormone To Prevent the Alterations Produced by 6-Methylprednisolone (Medrol) on the Growing Bone in Rats (1963) (5)
Sexual Maturation of Israeli Boys of European and Middle Eastern Origin. Preliminary Study (1963) (4)
The interaction of cortisone and vitamin D on bones of rachitic rats. (1958) (4)
Anorexia nervosa associated with hormonal replacement therapy in an adolescent gonadal dysgenesis. (1982) (4)
Molecular Mutations in the Human Growth Hormone Axis (2002) (4)
Discrimination between growth hormone (GH) deficiency of hypothalamic or pituitary origin: an aid in selecting patients for GH-releasing hormone (RH) prolonged therapy. (1988) (4)
Growth Hormone Secretagogues (1995) (4)
Diagnosis of growth hormone deficiency in childhood. On behalf of the Growth Hormone Research Society. (2000) (4)
Possible link between month of birth and childhood leukemia supports the hypothesis of an infectious etiology. (2010) (4)
XY gonadal dysgenesis associated with hGH and gonadotrophin deficiencies (1979) (4)
Diagnosis of Laron Syndrome (2011) (4)
Behavior in girls with true precocious puberty. (1986) (4)
The Era of Cadaveric Pituitary Extracted Human Growth Hormone (1958-1985):Biological and Clinical Aspects. (2018) (4)
An Attenuation in the Incidence of Early Childhood Diabetes Correlates With Introduction of Rotavirus Vaccination in Israel. (2020) (4)
A Case of Laron Syndrome Diagnosed in Slovenia (1994) (4)
ACTH deficiency in children and adolescents (clinical and psychological aspects). (1970) (4)
Small testes in prepubetal boys with Klinefelter's syndrome. (1971) (4)
Characterization of hGH from patients with LTD by a human liver radio-receptor assay (RRA) (1981) (4)
Insulin analogues display atypical differentiative activities in skin keratinocytes (2015) (4)
A child with phenotypic Laron dwarfism and normal somatomedin levels. (1989) (4)
Growth hormone (GH)-releasing heptapeptide, but not GH-releasing hormone, inhibits thyrotropin-stimulated thyroid hormone secretion and cAMP formation in cultured human thyroid follicles. (1995) (4)
Anthropometric indices at age 17 years of full-term neonates born short (2009) (4)
The Olfactory Receptor Gene Product, OR5H2, Modulates Endometrial Cancer Cells Proliferation via Interaction with the IGF1 Signaling Pathway (2021) (4)
Conclusions and Future Studies (2011) (4)
Letter: Plasma glucagon response to arginine infusion in children and adolescents with constitutional (familial) short stature. (1974) (4)
Genome-Wide Analyses Identify Filamin-A As a Novel Downstream Target for Insulin and IGF1 Action (2018) (4)
Growth, development, puberty and adult height of patients with congenital multiple pituitary hormone deficiencies. (2016) (4)
Health and Lifestyle of Adult Patients with Congenital Isolated Growth Hormone Deficiency Treated in Childhood. (2019) (4)
[Rehabilitation of children and adolescents with growth retardation]. (1975) (4)
Gonadotrophin release in untreated congenital virilising adrenal hyperplasia. (1978) (4)
Somatomedin-1 (Insulin-Like Growth Factor-I) in Clinical Use (2012) (4)
Pituitary insufficiency in cleft palate or lip. (1986) (4)
Evidence for a therapeutic effect of dl-propranolol in benign and malignant insulinoma: report of three cases (1983) (4)
Relation of puberty to development of nonproliferative retinopathy in young IDDM patients (1992) (3)
Response to LH-RH and HCG in two brothers with the Reifenstein syndrome. (1976) (3)
Hyperprolactinaemia in a boy with hypothyroidism due to an ectopic thyroid. (1978) (3)
Reliability of the Eyetone instrument and the Reflectance Meter in instant blood glucose determinations. (1978) (3)
EFFECT OF TESTOSTERONE AND METHANDROSTENOLONE (DIANABOL) ON PLASMA FREE FATTY ACIDS IN INTACT FEMALE AND CASTRATED MALE RATS. (1965) (3)
The comparative effect of 6 alpha-fluoroprednisolone, 6 alpha-methylprednisolone, and hydrocortisone on linear growth of children with congenital adrenal virilism and Addison's disease. (1968) (3)
Childhood-onset growth harmone deficiency, cognitive function and brain N-acetylaspartate (2006) (3)
Effect of triiodothyronine administration on the plasma TSH and prolactin responses to TRH in patients with hypothalamic-pituitary insufficiency. (1979) (3)
Immunological Investigations of Sheep Prolactin (1963) (3)
A simple diagnostic screening test for children with short stature - with emphasis on genetic defects along the GH axis. (2006) (3)
Prediabetes - are we ready to intervene? : 8th International Beilinson Symposium on Prediabetes, Herzliya, October 20-25, 1991 (1993) (3)
Comparison between the Reflomat reflectance meter and the autoanalyzer for instant blood sugar measurements. (1978) (3)
P01-22 Genome-wide analysis of cancer protection pathways in Laron Syndrome patients (2012) (3)
Glucose Intolerance in Children and Young Adults with Dwarfism due to HGH Deficiency and with the Syndrome of Dwarfism and High Plasma IR-HGH (1977) (3)
Klinefelter's Syndrome: Early Diagnosis and Social Aspects (1972) (3)
A Novel Variant c.97C>T of the Growth Hormone Releasing Hormone Receptor Gene Causes Isolated Growth Hormone Deficiency Type Ib (2018) (3)
The use of computers in the control of diabetes in children and adolescents. (1989) (3)
Comparative HGH response to i.v. glucagon and i.v. arginine stimulation tests in children and adolescents (1976) (3)
The action of cortisone on the teeth of rachitic rats. (1956) (3)
Effect of anorexia nervosa on gonadotrophin secretion in a patient with gonadal dysgenesis. (1983) (3)
HLA Associations in Late‐Onset 21‐Hydroxylase Deficiency in Israel (1985) (3)
Unusual association of insulin-dependent diabetes mellitus with congenital myasthenia gravis and autoimmune thyroid disease. (1984) (3)
Total and l(+) Tartaric Acid Inhibited Rat Serum Acid Phosphatase (1960) (3)
Interaction between 19-nor-androstenolone phenylpropionate (durabolin) and 6-methylprednisolone (medrol) on the bones of rats fed a low calcium diet. (1963) (3)
Lipolytic effects of sheep beta-lipotropin in rat adipose tissue: interaction with theophylline and dihydroergotamine. (1974) (3)
The occurrence of 3-alpha, 21-dihydroxy-pregnane, 11-20-dione (tetrahydro compound A) in the serum of children. (1957) (3)
Linear Growth Pattern of Untreated Laron Syndrome Patients (2011) (3)
Plasma LH and FSH response to LRH and plasma testosterone levels in boys with irregular puberty. (1977) (3)
The role of growth hormone on fetal development in utero. (1972) (3)
Vascular complications of childhood diabetes mellitus (1992) (3)
Asthmatic attack associated with oral clonidine test (1984) (3)
ZYG11A Is Expressed in Epithelial Ovarian Cancer and Correlates With Low Grade Disease (2021) (3)
Recent progress in medico-social problems in juvenile diabetics : proceedings of the 5th International Beilinson Symposium, Herzliya-on-Sea, October 25-30, 1981, part II (1983) (3)
The Teeth in Patients with Laron Syndrome (2011) (3)
IGF-I Treatment of Patients with Laron Syndrome (2011) (3)
THE INFLUENCE OF ORAL GLUCOSE LOADING ON THE INSULIN RESPONSE TO I.V. GLUCAGON IN CHILDREN AND ADOLESCENTS (1975) (3)
THE IMMUNOLOGICAL PROPERTIES OF HUMAN ACTH (1964) (3)
Clinical Use of Somatomedin-1 (1999) (3)
Professor Laron comments (1976) (3)
Serum‐total and L (+)‐Tartaric‐acid‐inhibited Acid‐phosphatase Activity in Various Diseases in Childhood 1 (1959) (3)
Phenytoin in Metastatic Insulinoma (1975) (3)
Influence of medroxyprogesterone acetate therapy on carbohydrate metabolism in acromegaly. (1972) (3)
Clinical use of somatomedin-1: yes or no? (1999) (3)
Ultrasonographic observations in girls with central precocious puberty before and during therapy with the GnRH analogue D-TRP-LHRH (1990) (3)
Sleep and Sleep Disorders in Patients with Laron Syndrome (2011) (2)
GROWTH HORMONE (GH) IS NORMAL IN GIRLS WITH PRECOCIOUS PUBERTY DURING SUPPRESSIVE THERAPY WITH LH-RH ANALOGUE (D-TRP-6-LH-RH) (1986) (2)
Evaluation of long term growth response to hGH treatment (1981) (2)
Keratopathy associated with hypoparathyroidism and Addison's disease. (1981) (2)
Successful treatment of insulin lipoatrophy. A case report. (1979) (2)
Hepatomegaly due to self-induced hyperinsulinism. (1979) (2)
Hypothalamic hypopituitarism following Shigella encephalopathy. (1999) (2)
For Debate: The Controversy whether Rotavirus Vaccination Attenuates the Incidence of Childhood Type 1 Diabetes. (2020) (2)
Outptient Management of Diabetic Children (1969) (2)
The LH and FSH responses to LH-releasing hormone (LH-RH) in girls with true precocious puberty treated with cyproterone acetate (1977) (2)
Late Onset 21-Hydroxylase Deficiency in a Girl Mimicking True Sexual Precocity (1989) (2)
Effect of octreotide on 24-hour growth hormone and prolactin secretory patterns in acromegalics. (1991) (2)
Use of a Computer Program in the Treatment and Education of Young Diabetics (1987) (2)
Serum Prolactin in Untreated and IGF-I Treated Patients with Laron Syndrome (2011) (2)
A comment on normal intelligence in growth hormone receptor deficiency. (1998) (2)
Cytoplasmic islet cell antibodies in type I diabetics in Israel and their first-degree relatives. (1985) (2)
Effect of diphenylhydantoin on insulin response in the oral glucose tolerance test in children and adolescents. (1973) (2)
The nomenclature of neonatal size--a conundrum. (2009) (2)
Growth hormone response to TRH in families multiply affected with schizophrenia (1992) (2)
Growth Factors (1996) (2)
Recent Progress in Pediatric Endocrinology (1978) (2)
135 PUBERTAL DEVELOPMENT AND FINAL HEIGHT IN CIRLS WITH CENTRAL PRECOCIOUS PUBERTY (CPP) AFTER THERAPY WITH THE Gn-RII ANALOC D-TRP-6-LII-RII (1988) (2)
A MICROCOMPUTER PROGRAM AS AN AID IN NUTRITIONAL COUNSELLING AND FOLLOW-UP IN DIABETES AND OBESITY (1986) (2)
Optimum Use of Growth Hormone in Children (1991) (2)
IGF-I Binding Proteins in Laron Syndrome (2011) (2)
Correlation between plasma growth hormone and insulin and blood glucose concentrations in premature infants. (1976) (2)
Psychological Aspects in Patients with Laron Syndrome (2011) (2)
P-74 Congenital IGF-I deficiency effects on dental morphology and histology in patients with Laron syndrome (2008) (2)
Glucosuric effect of anabolic steroids in juvenile diabetics. (1965) (2)
Infantile nephrosis in two siblings. Case report. (1960) (2)
Nonalcoholic Fatty Liver Disease (Nafld) in Patients with Laron Syndrome (2011) (2)
Comparison of the Growth Promoting Response of IGF-I in Children with Laron Syndrome with that of hGH in Children with Isolated GH Deficiency (2011) (2)
Successful treatment of Cushing's disease with o,p'-DDD followed by pituitary irradiation in a 19-year-old male patient. (1979) (2)
Clomiphene in pubertal-adolescent gynecomastia. (1978) (2)
The incidence of childhood IDDM in various ethnic groups in Israel : a population-based study―1989 (1992) (2)
The purification and characterization of a lipolytic factor from bovine pituitaries. (1977) (2)
For Debate: Growth Hormone Treatment of Infants Born Small for Gestational Age should be Started at or before the First Year of Age. (2016) (2)
Neuroendocrine Response to Trihexyphenidyl in Depressed Patients (1992) (2)
Atherosclerosis starts in childhood--fact, myth or insinuation? (1991) (2)
Repeated purifications of (125I)HGH for radioimmunoassay. (1973) (2)
A study of the reliability of the Eyetone and Reflectance Meter in instant blood glucose determinations. (1978) (2)
Hypoglycaemia in newly diagnosed diabetic children and adolescents — comparison between human and porcine insulin (1988) (2)
[Plasma C-peptide levels in juvenile diabetes]. (1981) (2)
Utilization of Computers in Regional Diabetes Services (1985) (2)
87 EFFECT OF CRF 1–41 AS COMPARED TO INSULIN HYPOGLYCEMIA (ITT) ON PLASMA CORTISOL AND ACTH IN SUBJECTS WITH INTACT OR DEFECTIVE HYPOTHALAMIC-PITUITARY FUNCTIONS (1985) (2)
GH and GHBP activity and not IGF-1 and its receptor activity express growth velocity reduction during treatment of central precocious puberty by a superactive GNRH analogue. (1994) (2)
40 hGH RESPONSE TO GH-RH 1–44 IN OBESITY OF VARIOUS ETIOLOGIES (1985) (2)
Standardization of oral glucose tolerance tests [proceedings]. (1977) (2)
Effect of gonadotrophin therapy on testicular volume and sexual development in adolescent boys with hypogonadotrophic hypogonadism. (1971) (2)
To be or not to be "TALL"? (2012) (2)
Use of the Whole Country Insulin Consumption Data in Israel to Determine the Prevalence of Type 1 Diabetes in Children <5 Years of Age Before and During Rotavirus Vaccination (2021) (2)
Long-Term IGF1 Stimulation Leads to Cellular Senescence via Functional Interaction with the Thioredoxin-Interacting Protein, TXNIP (2022) (2)
Comprar Laron Syndrome - From Man to Mouse | Laron, Zvi | 9783642111822 | Springer (2011) (2)
Natural History of Type I Diabetes Mellitus in Childhood (1987) (2)
INFLUENCE OF HEAT AND PEPSIN DIGESTION ON THE IMMUNOCHEMICAL PROPERTIES OF SHEEP PROLACTIN. (1965) (2)
Safety of pituitary growth hormone (1994) (2)
Growth Hormone Treatment in Israel (1993) (2)
Letter: Phenytoin in metastatic insulinoma. (1975) (2)
190 LONG TERM THERAPY OF PRECOCIOUS PUBERTY WITH THE SUPERACTIVE LH-RH ANALOGUE D-TRP-6-LH-RH (1985) (2)
Diagnostic uses of LHRH (1984) (1)
Relationship between food intake and insulin response to oral glucose tolerance test in short lean children. (1977) (1)
Precocious sexual development In a boy with Addison's disease (1981) (1)
Activity of acid phosphatase in the cerebrospinal fluid of children. (1961) (1)
INFLUENCE OF ANDROGENS ON FAT METABOLISM (1964) (1)
Imaging Findings in Laron Syndrome (2011) (1)
Effect of cortisone on the development of nephrocalcinosis and ectopic bone in the ischemic rat kidney. (1962) (1)
Stimulation of adipose tissue lipolysis in vitro by enzyme-digested human growth hormone. (1966) (1)
Stimulation of 3H glucosamine incorporation Into chick cartilage as an Index of serum somatomedin activity (1981) (1)
39 EFFICIENCY OF GROWTH PROMOTING ACTION OF hGH IS HIGHEST IN VERY YOUNG DEFICIENT CHILDREN (1985) (1)
Head Shape, Size, and Growth of Untreated Patients with Laron Syndrome (2011) (1)
Growth-Hormone-Resistant Syndromes (1986) (1)
Subject Index Vol. 53, Suppl. 3, 2000 (2000) (1)
For debate: did the small-bodied hominis from flores (Indonesia) suffer from a molecular defect in the growth hormone receptor gene (Laron syndrome)? (2006) (1)
Advances in the treatment of diabetes in childhood. (1988) (1)
Approximate confidence limits for the concentration of insulin in radioimmunoassay (1974) (1)
Effects of Long-Term Administration of IGF-I on the Adipose Tissue and Carbohydrate Metabolism in Children with Laron Syndrome (2011) (1)
Lack of transplacental passage of growth hormone in rabbits (1966) (1)
Idiopathic hypoproteinemia; associated with clubbing, eosinophilia and gastric anacidity; case report and review of the literature. (1955) (1)
Serum‐total and L (+)‐Tartaric‐acid‐inhibited Acid‐phosphatase Activity in Various Diseases in Childhood 1 (1959) (1)
Muscle–Bone Relationship in Patients with Laron Syndrome (2011) (1)
1372 CARDIO-RESPIRATORY DEPRESSION AND PLASMA BETA ENDORPHIN LEVELS IN LOW BIRTH WEIGHT INFANTS DURING THE FIRST DAY OF LIFE (1985) (1)
Familial isolated growth-hormone deficiency with advanced sexual maturation. (1993) (1)
Subject Index, Vol. 7, 1976 (1976) (1)
Interpretation of glucose and insulin curves during the oral glucose tolerance test. (1972) (1)
Investigations to Determine the Cause of Obesity in Patients with Laron Syndrome (2011) (1)
Immunological Aspects of Anterior Pituitary Hormones with Special Emphasis on Growth Hormone (1965) (1)
Hand, Foot, and Organ Size and Growth in Untreated and IGF-I Treated Patients with Laron Syndrome (2011) (1)
Habilitation and rehabilitation of juvenile diabetics : Proceedings of the first Beilinson Symposium on Juvenile Diabetes (1970) (1)
The Hematopoietic System in Patients with Laron Syndrome (2011) (1)
OR4-2: Growth hormone is a more potent growth stimulating hormone than IGF-I: clinical perspective (2014) (1)
The Multidisciplinary Team for Children and Adolescents with Diabetes Mellitus (2002) (1)
Safety of pituitary growth hormone extracted with acetone/acetic acid (1994) (1)
Thyrotropin, prolactin and growth hormone responses to thyrotropin releasing hormone in obsessive-compulsive disorder (1989) (1)
Screening for and experimental treatment of prediabetics: ethical and legal perspectives. Discussion (1993) (1)
Effect of GH status on renal insulin-like growth factor I (IGF-I), IGF-I receptor, IGF-binding protein (IGFBP) and GH receptor mRNA levels in prepubertal rats (1994) (1)
EFFECT OF HEAT ON THE IMMUNOLOGICAL PROPERTIES OF HUMAN, BOVINE AND OVINE GROWTH HORMONE. (1964) (1)
Serum Lipids in Patients with Laron Syndrome (2011) (1)
Insurance of diabetics. Discussion (1993) (1)
Psycho-social aspects of children and adolescents with diabetes (1989) (1)
Dynamics of basal pituitary gonadotropin secretion and responsiveness to LRH following estradiol benzoate in normal girls. (1982) (1)
Adverse Effects Encountered During IGF-I Treatment of Patients with Laron Syndrome (2011) (1)
Klinefelter's syndrome in adolescence. (1982) (1)
Comparison of one daily injection of NPH and crystalline PZI insulins on urinary glucose in diabetic children (2007) (1)
THE IMMUNOLOGICAL PROPERTIES OF GROWTH HORMONE AFTER ENZYME HYDROLYSIS AND HEATING (1964) (1)
Current problems in diabetes. (1956) (1)
Cardiovascular Aspects in Laron Syndrome Patients (2011) (1)
Testicular volumes of adolescents. (1983) (1)
Laron Syndrome Patients with Congenital IGF-I Deficiency Seem Protected from Malignant Diseases (2011) (1)
Identical growth hormone-stimulating potency in man of GH-RH1-29 and GH-RH1-44. (1987) (1)
[The use of synthetic gonadotrophin releasing hormone in diagnosis of disorders of puberty]. (1974) (1)
Muscle Force and Endurance in Untreated Adult and IGF-I Treated Children with Laron Syndrome (2011) (1)
LH AND FSH RESPONSE TO LH-RH IN 27 GIRLS WITH PRECOCIOUS PUBERTY (1975) (1)
Orthopedic Problems in Laron Syndrome (2011) (1)
Persistently low immunoreactive and normally bioactive plasma LH during male puberty. (1989) (1)
Hospitalization Versus Out-Patient Care of Diabetes (1977) (1)
Psychological Aspects of Childhood Diabetes (1984) (1)
Lifelong Serum Growth Hormone Levels in Patients with Laron Syndrome (2011) (1)
Identification of UDP-Glucuronosyltransferase 2B15 (UGT2B15) as a Target for IGF1 and Insulin Action (2022) (1)
Hypothesis: Viral infections of pregnant women may be early triggers of childhood type 1 diabetes and other autoimmune disease. (2023) (1)
Preventing type I diabetes mellitus. (2004) (1)
Changes in plasma amino acids metabolites, caused by long-term IGF-I deficiency, are reversed by IGF-I treatment - A pilot study. (2020) (1)
Multidisciplinary Ambulatory Care for Diabetic Children: Reply (1980) (1)
Human growth hormone. (1966) (1)
Psychological aspects of balance of diabetes in juveniles : 3rd International Beilinson Symposium, Herzlia 1975, Part II (1977) (1)
Pattern of month of birth in diabetic and non-diabetic adults. (2002) (1)
Social and vocational adjustment of 38 hjgh deficent patients after termination of thearpy (1984) (1)
[Comparison between growth hormone secretion during sleep and provocative tests in children and adolescents]. (1980) (1)
Plasma C-Peptide in Children and Adolescents with Newly Diagnosed Insulin Dependent Diabetes Mellitus (1985) (1)
The early history of Pediatric - Endocrinology. (2003) (1)
ADVANTAGES OF THE hGH 24hr SECRETORY PATTERN IN DISTINGUISHING GROWTH DISORDERS (1988) (1)
The relationship between serum levels of prolactin and growth hormone in the early postnatal period (2017) (1)
P-55 Hearing loss in patients with Laron syndrome (primary growth hormone insensitivity) is reversed by early IGF-I replacement therapy (2008) (1)
The adipose child. Medical and psychological aspects. (1976) (1)
[Morphological and biochemical changes in the placenta of streptozotocin-induced diabetic rats]. (1976) (1)
Ectopic thyroid in siblings (1991) (1)
Abstracts (Part 4 of 6) (1989) (1)
[Nanism with high values of GH and no generation of somatomedin after hGH (Laron's syndrome). Clinico-biochemical study of 8 cases]. (1985) (1)
Psychological aspects of diabetes in children and adolescents : proceedings of the 5th International Beilinson Symposium, Herzliya-on-Sea, October 25-30, 1981, part I (1982) (1)
Abstracts (Part 3 of 6) (1989) (1)
Influence of the mode of administration of luteinizing hormone-releasing hormone on the response of plasma luteinizing hormone and follicle-stimulating hormone in various disorders of puberty. (1977) (1)
Letter to the Editor - responses to Weisntein D, Simon M, Yehezkel E, Laron Z, Werner H. Insulin analogues display IGF-I-like mitogenic and antiactivity in cultured cancer cells. (2013) (1)
THE SYNDROME OF PITUITARY DWARFISM WITH HIGH SERUM CONCENTRATION OF GROWTH HORMONE (1967) (1)
Habilitation and rehabilitation of juvenile diabetics : proceedings (1970) (1)
hGH RESPONSE TO REPEATED GH-RH 1-44 ADMINISTRATION IN HYPOPITUITARY CHILDREN (1986) (1)
The Adipose Tissue in Patients with Laron Syndrome (2011) (1)
ANAPHYLACTIC REACTION TO ACTH. REPORT OF A CASE WITH SEROLOGICAL STUDIES. (1963) (1)
THE CORRELATION BETWEEN IMMUNOLOGICAL AND BIOLOGICAL PROPERTIES OF BOVINE AND SHEEP GROWTH HORMONE DIGESTED BY PEPSIN OR CHYMOTRYPSIN: IMMUNOLOGICAL AND METABOLIC STUDIES IN MAN (1966) (1)
Non-traditional risk factors for atherosclerosis in high risk children. (1996) (1)
Heterogeneity of pituitary and endogenous plasma human growth hormone from fetuses, premature and full-term newborns. (1976) (1)
6 GROWTH HORMONE GENE DELETION WITHOUT GROWTH ARREST (1985) (1)
Seasonality of birth in children with diabetes. Maternally transmitted infection might increase risk of diabetes. (2000) (1)
Induction of puberty in boys with delayed adolescence by methandrostenolone (1980) (1)
IGF-I Stimulation of Head Growth in Patients with Laron Syndrome (2011) (1)
The Effect of Glucose, Glucagon, Arginine, Vasopressin and ACTH on Plasma Insulin and Growth Hormone Concentrations in Normal Children and in Pituitary Insufficiency (1968) (1)
Evaluation of growth hormone secretion : physiology and clinical application : proceedings of a workshop of the International Growth and Development Association, Hinterzarten, June 23-24, 1982 (1983) (1)
LONG‐TERM ADMINISTRATION OF MEDROXY‐PROGESTERONE ACETATE (MPA) TO ACROMEGALIC PATIENTS (1974) (1)
The effect of hGH deficiency on the insulin response to glucagon after oral glucose loading (1977) (1)
Effect of starvation and 6-methylprednisolone (Medrol) on the acid phosphatase of rat liver and muscle. (1963) (1)
Late-onset type of 21-hydroxylase deficiency in childhood. (1982) (1)
Prolactin - Not Only a "Milk Hormone" Prolactin - Growth Hormone Relationships with Emphasis on Cancer. (2018) (1)
Augmentation by dihydroergotamine of lipolysis stimulated by shole and pepsin-digested human growth hormone. (1972) (1)
HLA linkage and B14, DRwl associations of non-classical 21-hydroxylase deficiency (1980) (0)
P01-7 Evaluation of the biological actions of insulin analogues in endometrial cancer cell lines (2012) (0)
Formation of COPES (1990) (0)
Hair, Skin, and Nails in Patients with Laron Syndrome (2011) (0)
Evidence of direct mitogenic activity of insulin and the insulin receptor in prostate cancer cell lines (2012) (0)
Professor Laron and Dr Roitman comment (1981) (0)
Anabolic Steroids (1963) (0)
LIPOLYTIC ACTIVITY OF ENZYME DIGESTED HUMAN GROWTH HORMONE (1965) (0)
Abstracts (Part 6 of 6) (1989) (0)
4.15 – Growth Hormone and Insulin-Like Growth Factor-I: Effects on the Brain (2017) (0)
Early Development, Growth and Puberty before and During Treatment of Congenital IGHD (2014) (0)
The Clinical Importance of IGF-I (2017) (0)
P64 Analysis of the interplay between the insulin receptor and IGF-I receptor signaling pathways in prostate cancer (2010) (0)
Repurification of a highly damaged 125I-HGH preparation. (1975) (0)
Thyroid Hormones in Untreated and IGF-I Treated Patients with Laron Syndrome (2011) (0)
LETTERS TO THE EDITORTo the Editor (1980) (0)
Clinical use of growth hormone: which and to whom (1987) (0)
ECTOPIC THYROID IN SIBLINGS. REPLY (1991) (0)
The Syndrome of Juvenile Diabetes Mellitus and Optic Nerve Atrophy — Report on Two Siblings (1977) (0)
The second to fourth digit ratio in patients with congenital IGF-1 Deficiency. (2019) (0)
Self-montoring of blood glucose during pregnancy in women with juvenile Diabeters. (1980) (0)
Neurological Aspects in Laron Syndrome (2011) (0)
MON-LB018 Depot-Specific Differences in Adipose Tissue Morphology with Laron Syndrome (2019) (0)
Adiponectin and Leptin in Laron Syndrome (2011) (0)
[Congenital hypothyroidism due to athyreosis]. (1983) (0)
Basketball not only for the tall. (2006) (0)
Limb Lengthening - for Whom, When and How? (1999) (0)
[Treatment of precocious puberty with cyproterone]. (1978) (0)
Long Term Experience with a Superactive GnRH Analog in the Treatment of Precocious Puberty (1990) (0)
Psychological Factors in Diabetes Mellitus (1980) (0)
Peptides modulating the activity of the FMI-1 and their applications (2009) (0)
[DIABETES INSIPIDUS IN CHILDREN. REPORT ON 3 CASES]. (1963) (0)
[Glycosylated hemoglobin as an index of diabetic control in juvenile diabetes]. (1979) (0)
History of the Israeli Cohort of Laron Syndrome Patients (1958–2009) (2011) (0)
Contents Vol. 208, 2004 (2004) (0)
Intellectual Function of Girls with Precocious Puberty (1984) (0)
Response to European Journal of Endocrinology 1997 137 459-466 and 450-452: Effect of GH on lipoprotein (A) in GH deficiency. (1998) (0)
RESEARCH The Globe and Orbit in Laron Syndrome (2011) (0)
Attitude of nonaffected and affected siblings to juvenile diabetes: a retrospective study in multidiabetic families. Discussion (1993) (0)
Comparison of Commonly Used Methods to Predict the Final Height in Constitutional Tall Stature (2022) (0)
European Society for Paediatric Endocrinology (ESPE) / Lawson Wilkins Pediatric Endocrine Society (LWPES): 3rd Joint Meeting, Jerusalem, October-November 1989: Abstracts (1989) (0)
Study of biological determinants of the prediabetic state in cystic fibrosis (Discussion) (1993) (0)
Subject Index, Vol. 36, 1991 (1991) (0)
Chapter 20 – Treatment of Children with Short Stature by Growth Hormone Secretagogues (1999) (0)
schizophrenic patients. Abnormal growth hormone response to TRH in chronic adolescent (2013) (0)
Contents, Vol. 10, 1983 (1983) (0)
Peptides that modulate the activity of IGF and its applications (2010) (0)
Bone Age Estimation for Whom by Whom? By Which Method? (2015) (0)
Focal Epilepsy in Individuals with Laron Syndrome (2022) (0)
Skinfold Measurements in Diabetic Children and Adolescents (1977) (0)
Prolactin response to growth hormone stimulation tests. (2022) (0)
Childhood diabetes mellitus with emphasis on perinatal factors. (2006) (0)
42 SERUM GROWTH HORMONE BINDING PROTEIN (GH-BP) IN PRE-PUBERTAL CHILDREN IS CORRELATED WITH HEIGHT (1988) (0)
Penile and testicular size in isolated GH deficiency (IGHD) and response to hGH treatment (1981) (0)
CIGssificGfion of growfh insensitivity syndrome (1993) (0)
European Society for Paediatric Endocrinology (ESPE) / Lawson Wilkins Pediatric Endocrine Society (LWPES): 3rd Joint Meeting, Jerusalem, October-November 1989: Proceedings Mode of Action of Hormones / hGH Therapy / Autoimmune Aspects of IDDM (1990) (0)
Classification of patients with GH deficiency (GHD) according to the response to GH-RH (1984) (0)
156 SODIUM-LITHIUM COUNTERTRANSPORT ACTIVITY IN DIABETICS AND THEIR PARENTS (1991) (0)
HETEROGENEITY OF PITUITARY AND ENDOGENOUS PLASMA HGH FROM FETUSES, PREMATURES AND FULL-TERM NEW BORNS (1975) (0)
P15 Long-term administration of hGH or IGF-I increase body adiposity and serum cholesterol (2010) (0)
Title Page/Table of Contents (2022) (0)
Oral clonidine, an effective hGH provocative test (1979) (0)
[Clinical application of serum somatomedin determination]. (1979) (0)
108 IGF-BINDING TO READ BLOOD CELLS OF SIIORT AND TALL BOYS. COMPARIOSON WITH CH-BINDING PROTEIN LEVELS (1988) (0)
Activity of acid phosphatase in cerebroq)inal fluid of children the (1961) (0)
Bone Mineral Density in Untreated and IGF-I or Alendronate-Treated Patients with Laron Syndrome (2011) (0)
Insulin secretion in children familial short stature itb constitutional (1973) (0)
Head Circumference, Birth Length, and Weight of Neonates of Mothers with Hypothyroidism (2018) (0)
Future trends in juvenile diabetes : therapy and research : proceedings of the 6th International Beilinson Symposium, Herzliya-on Sea, October 21-28, 1984 (1986) (0)
COMPARISON OF TWO RTA METHODS FOR IGF-1 USING EXTRACTED SERA OR WHOLE PLASMA (1988) (0)
24: Serum Sulfate Levels and Plasma hGH, in Patients with Low and Excessive hGH Secretion (1976) (0)
Lack of influence of arginine preloading on the insulin response to I.V. glucagon in children and adolescents (2007) (0)
[Treatment of diabetes insipidus with DDAVP, a synthetic analog of vasopressin]. (1975) (0)
Does Type 1 Childhood Diabetes Start In Utero (2015) (0)
Early Investigations: Characterizations of the Circulating Growth Hormone (2011) (0)
PLASMA LH, FSH AND TESTOSTERONE RESPONSE TO LH-RH IN B0YS WITH COMPENSATORY TESTICULAR HYPERTROPHY (1975) (0)
Genome-wide profiling of congenital insulin-like growth factor-1 deficient patients: translational implications in cancer preven- tion and metabolism (2017) (0)
OR02-2 CONGENITAL IGF-I DEFICIENT PATIENTS ARE PROTECTED FROM CANCER, NOT SO THEIR 1ST AND 2ND DEGREE RELATIVES (2006) (0)
THE ADVANTAGE OF INTERMITTENT HGH THERAPY IN PATIENTS WITH ISOLATED AND COMBINED HGH DEFICIENCY (1975) (0)
Treatment of Premature and Delayed Puberty with Luteinizing Hormone - Releasing Hormone and Its Analogs (1987) (0)
Does childhood type diabetes mellities start ?in utero? (2015) (0)
Insulin Sensitivity as Homa at Start and End of HGH Treatment of Children with Congenital (C) Ighd and Mphd (2019) (0)
Erratum to 'Identification of nephronectin as a new target for IGF1 action' [Eur J Canc 141 (2020) Pages 115-127]. (2021) (0)
Traumatic chiasmal syndrome with panhypopituitarism A case report (1986) (0)
PO2-23: Growth and puberty of children with congenital isolated growth hormone deficiency (2014) (0)
Glucose Tolerance and Insulin Secretion in Parents and Children with Familial Dwarfism and High Plasma Immunoreactive Growth Hormone ( lR-HGH ) and Familial Isolated Growth Hormone Deficiency * (2008) (0)
Prognosis of diabetes in children : an update on early and late complications : proceedings of the 7th International Beilinson Symposium on Late Prognosis of Juvenile Onset Diabetes, Jerusalem, November 1-7, 1987 (1989) (0)
Delayed puberty and hypoplastic uterus associated with hyperprolactinemia and successfully treated with bromocriptine (1984) (0)
P-57 HEREDITARY ASPECTS OF LARON SYNDROME (PRIMARY GROWTH HORMONE INSENSITIVITY) - A STUDY OF THE ISRAELI COHORT (2006) (0)
P01-21 Analysis of the effects of insulin analogues on proliferation and differentiation in skin keratinocytes (2012) (0)
Prediction of IDDM. Discussion (1993) (0)
Low incidence of Type I diabetes in Israeli children of all ethnic groups (1984) (0)
LARON TYPE DWARFISM IS NOT DUE TO A MUTATION IN OR NEAR THE HUMAN GROWTH HORMONE GENE (1984) (0)
Session 7. Turner's sybdrine, Prader‐Willi syndrome, McCune‐Albright syndrome (1993) (0)
A contribution to the interpretation of the Oral Glucose Tolerance (OGTT) (1972) (0)
Sex Hormone Binding Proteins and Sex Hormones in Untreated and IGF-I Treated Patients with Laron Syndrome (2011) (0)
A novel variant c . 97 C > T of the Growth Hormone Releasing Hormone Receptor gene causes isolated growth hormone deficiency type Ib Short title : Novel c . 97 C > T variant of GHRH receptor (2017) (0)
Endcrine studies in anorexia nervosa (AN) concurrent with XO gonadal dysgenesis (GD) (1981) (0)
Growth, Development and Puberty of Patients with Congenital Multiple Pituitary Hormone Deficiencies (2015) (0)
P-10 Mitogenic activity and signaling pathways elicited by long-acting insulin analogues Glargine and Detemir in colon cancer derived cell lines (2008) (0)
What ESPE Means to Me (2011) (0)
CONVENTIONAL STEROID THERAPY DOES NOT ADEQUATELY SUPPRESS 17OHP SECRETION IN CAH (1988) (0)
GH response to TRH in multicase families with schizophrenia (1994) (0)
Perinatal Development in Laron Syndrome (2011) (0)
METABOLIC STUDIES IN CHILDREN WITH CONSTITUTIONAL SHORT STATURE (1975) (0)
Liver Enzymes in Patients with Laron Syndrome (2011) (0)
The effect of dihydroergotamine on ACTH-stimulated lipolysis in rat adipocytes. (1973) (0)
The Adipose child : medical and psychological aspects : international symposium held in Tel Aviv, April 30 to May 3, 1975 (1976) (0)
The Good Fence Between Israel and Lebanon (1977) (0)
Adjustment and Rehabilitation Problems of Children, Adolescents, and Adults with Laron Syndrome (2011) (0)
Birth Length, Weight and Head Circumference of Neonates with IGF-I Receptor Mutations (2016) (0)
Wolfram syndrome. (1978) (0)
Glycosylated Hemoglobin (GHb) as an index of diabetes control in diabetic children and adolescents (1978) (0)
INFANTILE PYLORIC STENOSIS (1956) (0)
Laron Syndrome - From Man to Mouse - ReadingSample (2017) (0)
Kidney Functions in Untreated and IGF-I Treated Patients with Laron Syndrome (2011) (0)
[Effect of somatostatin in patients with high plasma growth hormone]. (1977) (0)
Fifty years of radioimmunoassay. (2007) (0)
Congenital hyperinsulinism, neonatal diabetes and the risk of malignancies: an international collaborative study. Preliminary communication (2015) (0)
Fiypothalamo-pituitary hormone insufficiency as 4 sociated with cleft lip and palate (0)
Officers of the ESPE and the LWPES for 1989 (2004) (0)
Abbreviations ACTH : Adrenocorticotropic hormone FSH : Follicle-stimulating hormone GH : Growth hormone ITT : Insulin tolerance test LH : Luteinising hormone 1 1-OHCS : 1-Hydroxycorticosteroid T 4 : Thyroxine TRH : Thyroid-releasing hormone TSH : Thyroid-stimulating hormone group (0)
Abstracts (Part 5 of 6) (1989) (0)
SAFETY OF PITUITARY GROWTH HORMONE. AUTHORS' REPLY (1994) (0)
Contents, Vol. 7, 1976 (1976) (0)
Subject Index, Vol. 22, 1985 (1985) (0)
Comparison between NPH and PZI insulin in the treatment of diabetic children (1978) (0)
P03-41 Natural history of congenital isolated growth hormone deficiency (2012) (0)
Effect of insulin-like growth factor I on IGF binding proteins. (1993) (0)
At what stage of childhood obesity should the psychosocial team intervene? (2007) (0)
Glucosuria is a marker for prediabetes of slowly progressing IDDM (Discussion) (1993) (0)
Prevention of diabetes by viruses and viral proteins. Discussion (1993) (0)
Health Lifestyle and Obesity of Adult Patients with Congenital Isolated Growth Hormone Deficiency Treated in Childhood (2018) (0)
Four years experience with the microcomputer system "Diacon" in the treatment and education of diabetes. (1990) (0)
Summary of the Clinical History: The Laron Syndrome Clock (2011) (0)
Growth, genetics of (2018) (0)
Growth and Developmental Follow-up Forms (1998) (0)
Effect of serum from children with isolated hGH deficiency (IGHD) and Laron type dwarf ism (LTD) on skin fibroblasts (1978) (0)
Subject Index Vol. 208, 2004 (2004) (0)
Risk of Overweight in Adolescence among Offspring of Diabetic Mothers. (2017) (0)
LONG-TERM hGH TREATMENT OF SHORT PREPUBERTAL CHILDREN IMPROVES THEIR HEIGHT (1993) (0)
Subject Index Vol. 10, 1983 (1983) (0)
Previous Meetings and Presidents of the ESPE and the LWPES (1989) (0)
[The effect of long-term prednisone on growth and on the hypothalmic-pituitary-adrenal axis]. (1973) (0)
Enhanced hGH pituitary secretion rate associated with somatomedin deficiency as manifested in Laron type dwarfism (LTD) (1984) (0)
Diabetes in juveniles : medical and rehabilitation aspects : International Beilinson Symposium on the Various Faces of Diabetes in Juveniles, Jerusalem, Israel, 1972 (1977) (0)
Pediatric endocrinology and diabetology towards the new millennium. Expectations and limitations. (2000) (0)
MicroRNA 132-3p Is Upregulated in Laron Syndrome Patients and Controls Longevity Gene Expression (2021) (0)
The mitogenicity of insulin analogues in vitro relative to insulin and IGF‐I—Response to Kazda et al (2010) (0)
Genetic endocrine diseases. Foreword. (2006) (0)
Failure of a New TSH Inhibitor, the Methyl Ether of Triiodothy- ropropionic Acid, in the Treatment of Endocrine Exophthalmos (1963) (0)
Oral rehydration in acute infantile diarrhoea (2006) (0)
Plasma insulin response to arginine stimulation in children and adolescents with constitutional short stature according to sex, age, sexual development and skinfold thickness. (1978) (0)
Prolactin Secretion in Adolescent Boys with Hypogonadism (2009) (0)
Particular Aspects of the Management of Diabetes in Children (1989) (0)
Letter From Abroad: News From Israel (1981) (0)
Non-specific growth hormone stimulation by synthetic LH-RH in adolescent schizophrenics (1979) (0)
Contents, Vol. 29, 1976 (1976) (0)
Biology of IGF-I: Its interaction with insulin in health and malignant States Novartis Foundation Symposium No. 263 London, 13-16 October 2003 (2003) (0)
Dietary adjustment during self-blood-glucose monitoring in pregnant women with insulin-dependent diabetes mellitus. (1984) (0)
Message from the Editors (2001) (0)
10 C-PEPTIDE LEVELS IN NEWLY DIACNOSED TDDM AS AN INDICATOR FOR THE ADJUSTMENT OF THE INSULIN DOSE (1988) (0)
[Plasma growth hormone in juvenile diabetics]. (1974) (0)
[Endogenous insulin reserve in juvenile diabetics as a criterion for therapy]. (1974) (0)
Comparison between IGF-I and GH in perinatal growth (1998) (0)
Title Page / Table of Contents / Preface to the Second Edition / Opening Address / Introduction (1977) (0)
P-73 GF-I treatment of patients with Laron syndrome suppresses thrombopoietin levels but does not affect erythropoietin (2008) (0)
Neonates of hypothyroid mothers have a below-normal head circumference (2019) (0)
Paediatric rheumatology Seasonality of birth of patients with juvenile idiopathic arthritis (2015) (0)
[The development of international pediatric diabetes organizations]. (2010) (0)
Hearing in Patients with Laron Syndrome (2011) (0)
Contents, Vol. 22, 1985 (1985) (0)
Growth hormone (hGH) response to oral clonidine in obese children and adolescents (1981) (0)
Letters to the Editor: Why are Children with Klinefelter Syndrome Tall? (2020) (0)
HYPERANDROGENISM AS A CAUSE OF EARLY POLYCYSTIC OVARY SYNDROME (PCOS) IN GIRLS WITH CENTRAL PRECOCIOUS PUBERTY (CPP) (1993) (0)
55 Effect of oral clonidine on cortisol secretion in men (1982) (0)
Increase of serum lipoprotein (a), an adverse effect of growth hormone treatment. (2022) (0)
Abstracts (Part 1 of 6) (1989) (0)
Conclusions of an international workshop on evaluation of growth hormone secretion (Physiology and clinical application) (1982) (0)
Metabolic alterations during prediabetes' (Discussion) (1993) (0)
76 PROLACTIN SECRETION IN 149 hGH DEFICIENT CHILDREN (1988) (0)
Prevention of diabetes in a large cohort of schoolchildren. Discussion (1993) (0)
Use of 6-methylprednisolone (Medrol) in the treatment of nephrosis in children. (1961) (0)
Melphalan attenuates streptozotocin-induced diabetes in C57BL/6 and C3H3 mice. (1988) (0)
[The comprehensive, ambulatory, multidisciplinary team approach in the treatment of diabetes in children (author's transl)]. (1977) (0)
Editor's commentary: sex hormone priming. (2014) (0)
Insulin antibodies before the administration of insulin in type I diabetes mellitus (1986) (0)
171: Effect of hGH lack on the insulin response to glucagon (1976) (0)
97: Effect of Prolonged Clomiphene Citrate Administration to Boys with Retarded Sexual Development (1976) (0)
P14 Lifelong serum growth hormone levels in untreated patients with Laron syndrome (2010) (0)
From the Paediatric Endocrinology Club to the European Society for Paediatric Endocrinology: the early years of ESPE. (2011) (0)
Insulin receptor compensates for IGF1R inhibition and induces mitogenic activity in prostate cancer cell lines (2012) (0)
P76 Prolactin serum levels in untreated and IGF-I treated patients with Laron syndrome are elevated and suppressed by IGF-I treatment (2010) (0)
24-HOUR GH SECRETION PATTERN IN FAMILIAL TALL STATURE (1986) (0)
Sex reversal in childhood. Theoretical and psychological aspects. (1981) (0)
LETTERS TO THE EDITOR (1980) (0)
Sex-specific sensitivity of the hypothalamic pituitary axis to estradiol benzoate in normal children (1981) (0)
Pediatric and adolescent endocrinology. Volume 2. Medical aspects of balance of diabetes in juveniles. Proceedings of the 3rd International Beilinson Symposium, Tel Aviv, April 30 to May 2, 1975, part 1. (1977) (0)
Effect of growth hormone and prolactin on mouse transplantable mammary adenocarcinoma (1966) (0)
862 EVALUATION OF THE RENIN-ALDOSTERONE SYSTEM DURING HYPO- AND HYPERGLYCEMIA IN CHILDREN AND ADOLESCENTS (1978) (0)
Increased densities and calcifications in the finger bones of children. (1976) (0)
Biology of IGF-I (2003) (0)
Comparison of estrogen induced breast development in girls with hyper- or hypo-gonadotrophic hypogonadism (1981) (0)
Control of diabetes insipidus by the buccal administration of posterior pituitary powder (pitressin). (1957) (0)
Psychosocial support to children and adolescents with diabetes. (2008) (0)
Effect of hGH therapy on the head circumference in hypopituitary children (1978) (0)
Abstracts (Part 2 of 6) (1989) (0)
LOW IMMUNOREACTIVE (IR), NORMALLY BIOACTIVE LH IN MALES WITH DELAYED PUBERTY (1986) (0)
P-35 FOOT SIZE IN UNTREATED ADULT PATIENTS WITH LARON SYNDROME (LS) AND FOOT GROWTH IN CHILDREN WITH LS DURING IGF-1 THERAPY (2006) (0)
Prevention of minidose streptozocin-induced diabetes by N-acetylcysteine. Discussion (1993) (0)
Laron Syndrome Patients have an Abnormal Plasma Amino Acid Pattern (2018) (0)

This paper list is powered by the following services:

Other Resources About Zvi Laron

en.wikipedia.org

What Schools Are Affiliated With Zvi Laron?

Zvi Laron is affiliated with the following schools:

Image Attributions

Image Source for Zvi Laron